FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Central Admixture Pharmacy Services Cardioplegia Solution Recall

Cardioplegia Solution, Maintenance 8:1 low potassium, 24 mEq K, packaged in 500 mL per…

Central Admixture Pharmacy Services, Inc. · Allentown, PA

Risk level
Class II
Reported by FDA
May 31, 2023
Recall ID
D-0663-2023
Check your lot numberHow we source this data

Summary

Central Admixture Pharmacy Services recalled Cardioplegia Solution starting Apr 28, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0663-2023 on May 31, 2023. Reason: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Product description

Cardioplegia Solution, Maintenance 8:1 low potassium, 24 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0105-1.

Lot numbers, UPCs & expiration codes

Lot # 37-893846, Exp 04/28/2023; 37-895704, Exp 05/05/2023; 37-897079, Exp 05/11/2023; 37-897927, Exp 05/13/2023; 37-898814, Exp 05/18/2023; 37-900617, Exp 05/25/2023

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0663-2023
Classification
Class II
Status
Terminated
Recall initiated
Apr 28, 2023
FDA report date
May 31, 2023
Quantity
308 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Central Admixture Pharmacy Services, Inc.

Original FDA data

Every field from FDA enforcement report D-0663-2023, exactly as published.

Show all FDA fields
City
Allentown
State
PA
Status
Terminated
Country
United States
Event ID
92253
Address
6580 Snowdrift Rd Ste 100
Code information
Lot # 37-893846, Exp 04/28/2023; 37-895704, Exp 05/05/2023; 37-897079, Exp 05/11/2023; 37-897927, Exp 05/13/2023; 37-898814, Exp 05/18/2023; 37-900617, Exp 05/25/2023
Postal code
18106-9331
Report date
May 31, 2023
Product type
Drugs
Recall number
D-0663-2023
Classification
Class II
Recalling firm
Central Admixture Pharmacy Services, Inc.
Product quantity
308 bags
Termination date
Jun 22, 2025
Reason for recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cardioplegia Solution, Maintenance 8:1 low potassium, 24 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0105-1.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Apr 28, 2023
Initial firm notification
E-Mail
Center classification date
May 19, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0663-2023, published May 31, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls